TALLAC THERAPEUTICS, INC.

Profile

Company Names

TALLAC THERAPEUTICS, INC.

Addresses

866 MALCOLM ROAD, SUITE 100, BURLINGAME, CA 94010

Phone Numbers

(650) 681-0458

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$61,616,192.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-06-23 
$61,616,192.00 
$61,616,192.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTINE 
 
BRENNAN 
DIRECTOR
ENTRADA THERAPEUTICS, INC.   |  TALLAC THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  REDONA THERAPEUTICS, INC.
MICHAEL 
 
CARUSI 
DIRECTOR
ENDOGASTRIC SOLUTIONS INC   |  GI DYNAMICS, INC.   |  POWERVISION, INC.   |  GLUMETRICS INC   |  ALTURA MEDICAL, INC.   |  SECOND GENOME, INC.   |  EXPLORAMED NC7, INC.   |  TALLAC THERAPEUTICS, INC.   |  MEDISIX THERAPEUTICS, INC.   |  CALA HEALTH, INC.   |  WILLOW INNOVATIONS, INC.
ISAAC 
 
CHENG 
DIRECTOR
LIQUIDIA TECHNOLOGIES INC   |  BIOSCALE INC   |  EDISON PHARMACEUTICALS INC   |  ATREAON, INC.   |  SYNCHRONEURON INC.   |  AMYLYX PHARMACEUTICALS, INC.   |  TORPEDO DIAGNOSTICS, INC.   |  DNATRIX INC   |  ADJUVANCE TECHNOLOGIES INC.   |  INCARDA THERAPEUTICS, INC.   |  MEISSA VACCINES INC   |  TALLAC THERAPEUTICS, INC.   |  APNIMED, INC.   |  MEDRHYTHMS, INC.
RAN 
 
GENG 
DIRECTOR
CHAMELEON BIOSCIENCES, INC.   |  TALLAC THERAPEUTICS, INC.
COREY 
 
GOODMAN 
DIRECTOR
LIMERICK BIOPHARMA INC   |  IPIERIAN, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SECOND GENOME, INC.   |  MIRNA THERAPEUTICS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  ALEXO THERAPEUTICS LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  NFLECTION THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  TALLAC THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  ATTRALUS, INC.   |  INSAMO INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
JAUME 
 
PONS 
DIRECTOR
ALEXO THERAPEUTICS LTD   |  TALLAC THERAPEUTICS, INC.
HONG 
 
WAN 
EXECUTIVE OFFICER, DIRECTOR
TALLAC THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-07-22
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-23 
2020-07-27
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#